20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T37563 | C22 Ceramide (d18:1/22:0) | Cer(d18:1/22:0),C22 Ceramide,Ceramide (d18:1/22:0) | |
C22 Ceramide (d18:1/22:0) (C22 Ceramide), a long-chain ceramide containing behenic acid, is an endogenous bioactive sphingolipid.C22-Ceramide specifically inhibits MCSR and reduces C16 ceramide channel formation in isola... | |||
T35805 | C16 Sphingomyelin (d18:1/16:0) | Sphingomyelin 16:0,N-Palmitoyl-D-sphingomyelin | Endogenous Metabolite |
C16 Sphingomyelin (d18:1/16:0) (N-Palmitoyl-D-sphingomyelin) is a phospholipid analog of phospholipid bilayer membranes, which can be used to study biofilm activity. | |||
T35803 | C14 Ceramide (d18:1/14:0) | Cer(d18:1/14:0),N-Myristoyl-D-sphingosine | |
C14 Ceramide (d18:1/14:0) is an endogenous ceramide produced by ceramide synthetase 6, which can be used for Parkinson's research. | |||
T38354 | Lactosylsphingosine (d18:1) | Lactosylsphingosine (d18:1) | |
Lactosylsphingosine is a bioactive sphingolipid and a form of lactosylceramide that is lacking the fatty acyl group. Lyso-lactosylceramide (1-50 μM) reduces viability of human neutrophils in a concentration-dependent man... | |||
T38000 | Lysosphingomyelin (d18:1) | ||
Sphingomyelins are complex membrane lipids composed of phosphorylcholine, sphingosine, and an acylated group, such as a fatty acid. Lysosphingomyelin is a naturally-occurring lipid which is produced by the removal of the... | |||
T37291 | Lyso-Globotriaosylceramide (d18:1) | Lyso-Globotriaosylceramide (d18:1) | |
Lyso-globotriaosylceramide is a form of globotriaosylceramide that is lacking the fatty acyl group. It binds to Shiga toxin 1 (Stx1) in the presence of cholesterol and phosphatidylcholine but does not bind Stx2. It also ... | |||
T37928 | 13C6 Glucosylsphingosine (d18:1) | ||
13C6 Glucosylsphingosine (d18:1) is an isotopically enriched form of 1-β-D-glucosylsphingosine (d18:1) that is intended for use as an internal standard for the quantification of 1-β-D-glucosylsphingosine by GC- or LC-MS.... | |||
T37872 | C16 Galactosylceramide (d18:1/16:0) | C16 Galactosylceramide (d18:1/16:0) | |
C16 Galactosylceramide is a glycosphingolipid that contains a galactose moiety attached to a ceramide acylated with palmitic acid . | |||
T36323 | C8 Galactosylceramide (d18:1/8:0) | C8 Galactosylceramide (d18:1/8:0) | |
C8 Galactosylceramide is a synthetic C8 short-chain derivative of known membrane microdomain-forming sphingolipids. It increases the amount delivered and toxicity of doxorubicin in cancerous but not non-cancerous cells w... | |||
T37438 | C17 Globotriaosylceramide (d18:1/17:0) | C17 Globotriaosylceramide (d18:1/17:0) | |
C17 Globotriaosylceramide is a sphingolipid that has been used as an internal standard for the quantification of globotriaosylceramides in plasma and urine from patients with Fabry disease by GC-MS. | |||
T38282 | C22 Glucosylceramide (d18:1/22:0) | ||
C22 Glucosylceramide (d18:1/22:0) is an endogenous glucosylceramide. Glucosylceramides are major constituents of skin lipid membranes where they play a role in maintaining the water permeability barrier. They are precurs... | |||
T35809 | C20 Sphingomyelin (d18:1/20:0) | ||
C20 Sphingomyelin is a naturally occurring sphingolipid. Levels of C20 sphingomyelin are upregulated in the hippocampus of rats with diabetes induced by streptozotocin and in human plasma where it is positively correlate... | |||
T37564 | C4 Ceramide (d18:1/4:0) | C4 Ceramide (d18:1/4:0),Cer(d18:1/4:0) | |
C4 Ceramide is a bioactive sphingolipid and cell-permeable analog of naturally occurring ceramides. [1] [2] [3] It inhibits IL-4 production by 16% in EL4 T cells stimulated with phorbol 12-myristate 13-acetate when used... | |||
T38452 | L-threo Lysosphingomyelin (d18:1) | L-threo-Sphingosylphosphorylcholine,L-threo Lysosphingomyelin (d18:1) | |
L-threo Lysosphingomyelin (d18:1) (L-threo-Sphingosylphosphorylcholine) is a naturally occurring bioactive sphingolipid. It acts as a potent agonist for S1P receptors, with EC50 values of 19.3, 131.8, and 313.3 nM for hS... | |||
T35808 | C18:1 Ceramide (d18:1/18:1(9Z)) | Cer(d18:1/18:1(9Z)) | |
C18:1 Ceramide is a naturally occurring ceramide.[1][2][3] Levels of C18:1 ceramide are elevated in overweight and insulin-resistant mice and cattle.[1][2] C18:1 Ceramide is also increased in the plasma and ovarian tissu... | |||
T36140 | BODIPY-C12 Ceramide (d18:1/12:0) | BODIPY-C12 Ceramide (d18:1/12:0) | |
BODIPY-C12 Ceramide (B12Cer) is a fluorescently-tagged form of C12 ceramide, with excitation/emission maxima at 505/540 nm, respectively. It is a fluorescently-labeled sphingolipid and has been utilized for quantifying a... | |||
T36860 | C22 Sphingomyelin (d18:1/22:0) | C22 Sphingomyelin (d18:1/22:0) | |
C22 Sphingomyelin is a naturally occurring form of sphingomyelin . Plasma levels of C22 sphingomyelin positively correlate with hepatic steatosis severity in patients with chronic hepatitis C virus (HCV). C22 Sphingomyel... | |||
T38182 | C17 Sphingomyelin (d18:1/17:0) | C17 Sphingomyelin (d18:1/17:0) | |
C17 Sphingomyelin is a synthetic derivative of sphingomyelin that has been used as an internal standard for the quantification of sphingomyelin. | |||
T36859 | C16 Globotriaosylceramide (d18:1/16:0) | C16 Globotriaosylceramide (d18:1/16:0) | |
C16 globotriaosylceramide is an endogenous sphingolipid found in mammalian cell membranes that is synthesized from C16 lactosylceramide . C16 globotriaosylceramide acts as a receptor for Shiga toxin in B cell-derived Raj... | |||
T36858 | C12 Galactosylceramide (d18:1/12:0) | ||
C12 Galactosylceramide is a bioactive sphingolipid. It inhibits IL-4 production by 53.84% in EL4 T cells when used at a concentration of 10 μM. C12 Galactosylceramide reduces the growth of human papillomavirus type 16-as... |